Literature DB >> 1087321

Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide.

N Chiorazzi, D A Fox, D H Katz.   

Abstract

Exposure of BALB/c, A/J, and (BALB/c X A/J)F1 mice, which are IgE high responder animals, to total body x-irradiation ranging from 50 to 200 R resulted in a dose-dependent enhancement of the hapten-specific IgE antibody level as compared to unirradiated control mice. In contrast, anti-hapten antibody responses of the IgG class in these same animals were rarely enhanced, and when so, were of a lesser degree. This relatively selective augmentation of the IgE vs IgG antibody responses was observed in both unprimed and primed mice. By utilizing adoptive transfer systems, it was demonstrated that the enhancing effects of x-irradiation resulted from its action on the carrier-primed cell population and not upon the responding B cells or upon macrophages. The data presented herein suggest that this enhancement phenomenon is the result of the elimination of T cells (or their products) with suppressive functions and that these cells are neither dependent upon nor specific for the carrier antigen employed in the immunization. This hypothesis is given indirect support by the observations that treatment of the same strains of mice with cyclophosphamide, in doses known to abrogate suppressive T cell functions, resulted in a similar enhancing effect to that observed after low doses of x-irradiation. In addition an interesting difference between IgE and IgG precursor B lymphocytes was observed by the ability of IgE B cells to differentiate to the secretory state at a strikingly more rapid rate than IgG B lymphocytes when exposed to comparable T cell helper influences. These observations may provide important clues to the cellular mechanisms of the immune regulation of the IgE response and its relationship to allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087321

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Postmortem changes in hapten-specific IgE antibody responses in mice.

Authors:  Y Hieda; M Kageura; K Hara; S Kashimura
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

2.  Cancer immunotherapy.

Authors:  R E Falk
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

3.  The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.

Authors:  R E Anderson; W L Williams; S Tokuda
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

4.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

5.  Regulation by cytokines of eosinophilopoiesis and immunoglobulin E production in mice.

Authors:  T Takenaka; K Kuribayashi; H Nakamine; M Tsujimoto; Y Fukuhara; J Maeda; M Mihara; Y Uchiyama; Y Ohsugi
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Role of antigen structure in the regulation of IgE isotype expression.

Authors:  T Francus; G W Siskind; C G Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

Authors:  J Cottney; J Bruin; A J Lewis
Journal:  Agents Actions       Date:  1980-09

8.  Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis.

Authors:  P Andersson; R Brattsand
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

9.  Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide.

Authors:  M Harada; S Makino
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

10.  IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms.

Authors:  S S Chen; F T Liu; D H Katz
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.